Category: Divisions
A new dean for Carey Business School
June 11, 2012
Bernard T. “Bernie” Ferrari, an accomplished corporate strategist and management consultant to Fortune 50 companies, has been named the next dean of The Johns Hopkins University’s Carey Business School. Ferrari, whose appointment is effective July 1, is the second dean to lead the Carey Business School since it was established in 2007. He succeeds Yash […]
Johns Hopkins names new dean of Carey Business School
May 30, 2012
Bernard T. “Bernie” Ferrari, an accomplished corporate strategist and management consultant to Fortune 50 companies, has been named the next dean of The Johns Hopkins University’s Carey Business School. Ferrari, whose appointment is effective July 1, is the second dean to lead the Carey Business School since it was established in 2007. He succeeds Yash […]
Inaugural Levi Professor of Bioethics and Public Policy installed
May 21, 2012
Jeffrey Kahn, deputy director for policy and administration at the Johns Hopkins Berman Institute of Bioethics and an authority on research and public health ethics, was installed May 1 as the inaugural Robert Henry Levi and Ryda Hecht Levi Professor of Bioethics and Public Policy. Ronald J. Daniels, president of The Johns Hopkins University, was […]
Thomas Smith named director of palliative care for Johns Hopkins Medicine
November 14, 2011
Thomas Smith has been named director of palliative care for Johns Hopkins Medicine and the inaugural Harry J. Duffey Family Professor of Palliative Care in the School of Medicine’s Department of Oncology. In this new directorship, he will lead palliative care efforts throughout the system. “Tom has a national and international reputation as one of […]
JHU Press marks 30 years of ’36-Hour Day’ with 5th edition
November 14, 2011
When the Johns Hopkins University Press published The 36-Hour Day in 1981, the subject of the book—Alzheimer’s disease and related dementias—was little known and barely discussed. In the 30 years since, 2.5 million copies of the Nancy Mace and Peter Rabins–authored book have been sold, and the fifth edition—with 30,000 trade paper and 5,000 large-print […]
Researchers discover how breast cancer spreads to lungs
November 14, 2011
The spread of breast cancer is responsible for more than 90 percent of breast cancer deaths. Now, the process by which it spreads—or metastasizes—has been unraveled by researchers at Johns Hopkins. Reporting in two papers, the researchers have discovered the switch that enables breast cancer cells to travel to and be received in the lungs. […]
Sickle cell community forum to educate, empower patients
November 14, 2011
Johns Hopkins Medicine last week brought together community members to develop a communications campaign to engage patients, health care professionals and legislators in the fight against sickle cell disease. “Linking Awareness to Action”—a dinner, panel and group discussion—was the first of a four-part community forum series to educate and empower individuals living with sickle cell […]
Imagining their new community school
November 14, 2011
On a beautiful fall day last week, students of East Baltimore Community School walked five blocks to the site of their new school building, scheduled to open in August 2013. Students posted their dreams for the future, which were written on 3 x 5 cards, on the fence surrounding the site and performed a ribbon-cutting […]
Johns Hopkins Hospital contractors turn over keys to new facility
November 14, 2011
The Johns Hopkins Hospital becomes the official owner today of the new 1.6 million-square-foot facility that will house the Sheikh Zayed Tower and Charlotte R. Bloomberg Children’s Center. At 12:30 p.m., construction company officials will hand over a ceremonial key to Edward D. Miller, dean of the School of Medicine and CEO of Johns Hopkins […]
Combo ‘epigenetic’ therapy may restore anti-cancer gene activity
November 14, 2011
A new type of therapy aimed at reversing the gene silencing that promotes cancer-cell growth has shown promising results in a small clinical trial conducted by researchers at the Johns Hopkins Kimmel Cancer Center. Forty-five late-stage lung cancer patients who received a two-drug combination designed to restore anti-cancer gene activity survived about two months longer than […]